Computational Drug Repurposing Approach to Identify Novel Inhibitors of ILK Protein for Treatment of Esophageal Squamous Cell Carcinoma

Table 2

The top 10 drugs with minimum binding energy to the ILK crystal.

No.	Generic name	Molecular formula	Binding energy (kcal/mol)
d1	Nilotinib	C28H22F3N7O	−10.5
d2	Teniposide	C32H32O13S	−10.3
d3	Doxycycline	C22H24N2O8	−9.9
d4	Celsentri	C29H41F2N5O	−9.8
d5	Saquinavir	C38H50N6O5	−9.8
d6	Lumacaftor	C24H18F2N2O5	−9.7
d7	Rolapitant	C25H26F6N2O2	−9.7
d8	SQV	C38H50N6O5	−9.7
d9	Netupitant	C30H32F6N4O	−9.7
d10	Raltegravir	C20H21FN6O5	−9.7